contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


elekta-issues-a-sek-15-billion-bond-and-signs-a-revolving-credit-facility-of-sek-1-billion

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Elekta provides medical technology. The company specializes in the development of clinical solutions for the treatment of cancer and brain diseases. Elekta's treatment system and planning software for radiation therapy and radiation surgery as well as other software systems are used in the healthcare industry to identify and analyze various health conditions. Operations are conducted on a global level, with headquarters in Stockholm.

Elekta

STOCKHOLM – Elekta (EKTA-B.ST) announced today that it has issued a SEK 1.5 billion bond under its existing Medium Term Note Program with a total limit of SEK 5 billion. The bond is divided ...

<div class="mfn-preamble">STOCKHOLM – Elekta (EKTA-B.ST) announced today that it has issued a SEK 1.5 billion bond under its existing Medium Term Note Program with a total limit of SEK 5 billion. The bond is divided into three tranches with floating rates:</div><div class="mfn-body"><ul><li>SEK 250 million in the first tranche has a coupon rate of STIBOR 3 months plus a margin of 1.05%</li><li>SEK 500 million in the second tranche has a coupon rate of STIBOR 3 months plus a margin of 1.5%</li><li>SEK 750 million in the third tranche has a coupon rate of STIBOR 3 months plus a margin of 1.95%</li></ul>All coupon interest payments are made quarterly. Final terms of the bonds are available on Elekta’s website&nbsp;<a rel="noopener" href="http://www.elekta.com/">www.elekta.com</a>.Skandinaviska Enskilda Banken (SEB) and Danske Bank acted as lead manager for the issue.Elekta has signed an unsecured revolving credit facility of SEK 1 billion with a maturity date in September 2026, with an option to extend for an additional year upon the lenders’ approval. The facility further strengthens Elekta’s financial flexibility and liquidity profile.The credit facility is provided by Danske Bank and Skandinaviska Enskilda Banken (SEB).# # #For further information, please contact: Peter Nyquist, Head of Investor Relations Tel: +46 70 424 6127, e-post: <a rel="noopener" href="mailto:peter.nyquist@elekta.com">peter.nyquist@elekta.com</a> About Elekta As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit <a rel="noopener" href="http://www.elekta.com/">elekta.com</a> or follow <a rel="noopener" href="https://twitter.com/Elekta">@Elekta</a> on “X”, formerly known as Twitter.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments<hr><a rel="noopener" href="https://storage.mfn.se/70033a63-35eb-4915-974b-52ff096185bb/sweden-revolving-credit-facility-2024-en.pdf" class="mfn-primary">Sweden Revolving Credit Facility 2024 EN</a></div>

Elekta issues a SEK 1.5 billion bond and signs a revolving credit facility of SEK 1 billion

Stay up to date with our newsletter